Clinical Trial Update: A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the efficacy and safety of Staccato alprazolam in participants aged 12 and older with stereotypical prolonged seizures; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stereotypical Prolonged Seizures

Drugs mentioned

• Staccato Alprazolam (Alprazolam)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Stereotypical Prolonged Seizures | Phase 3 | Status: RECRUITING